ACTICOR BIOTECH: Availability of the 2021 Universal Registration Document and the Preparatory Documents for the Combined General Meeting of May 12, 2022

Regulatory News: ACTICOR BIOTECH (ISIN: FR0014005OJ5 ALACT) (Paris:ALACT), a clinical-stage biotechnology company developing an innovative drug for the treatment of cardiovascular emergencies, announces

Related Keywords

Mediolanum ,Lombardia ,Italy ,Paris ,France General ,France ,Faubourg Saint Jacques ,Bourgogne ,French ,Newton Biocapital ,Venture Investment ,French National Institute Of Health ,Regulatory News ,Universal Registration Document ,Combined General Meeting ,Des March ,Entreprises Paris Cochin ,Acticor Biotech ,Bulletin Des Annonces ,General Meeting ,Vaccine Pass ,French Commercial ,French Commercial Code ,French National Institute ,Medical Research ,Mirae Asset Capital ,Primer Capital ,Euronext Growth Paris ,Acticor ,Biotech ,Availability ,021 ,Niversal ,Registration ,Document ,Preparatory ,Documents ,Combined ,Eneral ,Meeting ,022 ,